Streetbeat News

Analyst Ratings

RXT

Rackspace Tech (NASDAQ:RXT) has received mixed analyst ratings in the last quarter, with an average 12-month price target of $1.79, which is a slight increase from the previous target of $1.75. The ratings include 1 somewhat bullish, 1 indifferent, 1 somewhat bearish, and 1 bearish rating. The high price target is $3.50 and the low is $1.00.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 8:00 pm

ACRDF

AYRWF

CNTMF

CURLF

GTBIF

The Viridian Chart of the Week analyzes the balance between valuation and credit risk in cannabis stocks post Q3 earnings. It uses EV/2024 Consensus EBITDA estimates and a proprietary Credit Risk Score to assess attractiveness. Green Thumb (GTBIF) ranks most attractive, while Cansortium (CNTMF) and AYR (AYRWF) offer a balance of low valuation and credit risk. Curaleaf (CURLF) and Acreage (ACRDF) appear less attractive due to high valuation multiples and poor credit scores, respectively. The Viridian Cannabis Deal Tracker monitors industry capital raises and M&A activity.

Portfolio Pulse from Viridian Capital Advisors

November 20, 2023 | 7:33 pm

KBH

Wedbush analyst Jay McCanless downgraded KB Home (NYSE:KBH) to Neutral from Outperform, maintaining a price target of $55. The downgrade reflects increased competition and a higher percentage of builders cutting home prices, as reported by the NAHB. Despite maintaining FY23 and FY24 volume estimates for KBH, McCanless sees more downside risk and has lowered EPS estimates for both years, citing competitive discounting and mortgage rate buydowns. KBH's Q3 FY23 sales outperformed consensus, but shares are down 1.15%.

Portfolio Pulse from Lekha Gupta

November 20, 2023 | 7:33 pm

SNOW

Citi analyst Tyler Radke has expressed a positive outlook on the data warehouse industry, particularly highlighting Snowflake Inc (NYSE:SNOW) after attending several industry events. Radke noted improved trends in new projects and large Hadoop migrations. Although optimizations at Snowflake continue, peak levels have been primarily reached according to partners and customers. Despite Databricks leading in next-gen use cases, there is optimism for Snowflake's upcoming product launches. Consequently, SNOW shares saw a 3.22% increase to $167.06.

Portfolio Pulse from Anusuya Lahiri

November 20, 2023 | 7:15 pm

FND

Truist Securities analyst Keith Hughes maintains a Buy rating on Floor & Decor Holdings Inc (FND) and increases the price target from $97 to $102. Hughes anticipates the flooring industry to rally first due to quick demand trend changes and expects FND to experience a turnaround and market share gains. The analyst predicts a strong 2025 for FND, driven by store openings and a demand recovery, and raises the 2024 EPS estimate to $2.08. FND's stock price has risen by 1.10% to $90.78.

Portfolio Pulse from Shivani Kumaresan

November 20, 2023 | 7:09 pm

RXT

Citigroup analyst Ashwin Shirvaikar has maintained a Sell rating on Rackspace Tech (NASDAQ:RXT) and reduced the price target from $1.50 to $1.25.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 7:08 pm

MSFT

Sam Altman and Greg Brockman, formerly of OpenAI, have been hired to lead a new advanced AI research team at Microsoft following their ouster from OpenAI. Analysts from Wedbush, Oppenheimer, and Evercore ISI view this as a positive move for Microsoft, with all maintaining an Outperform rating and setting price targets ranging from $410 to $432. Microsoft's stock was trading at $376.5 at the time of publication.

Portfolio Pulse from Surbhi Jain

November 20, 2023 | 7:02 pm

LLY

Eli Lilly (NYSE:LLY) has received predominantly bullish ratings from analysts in the last quarter, with 3 bullish, 11 somewhat bullish, and 1 indifferent rating. The average 12-month price target for LLY is $642.33, which is an 8.29% increase from the previous target of $593.14. The high estimate is $722.00 and the low is $535.00. Analysts' ratings are based on financial predictions and company performance, and are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 7:00 pm

DCPH

Over the past quarter, Deciphera Pharmaceuticals (NASDAQ:DCPH) received 4 analyst ratings: 2 bullish, 1 somewhat bullish, and 1 indifferent. The 12-month price targets for DCPH suggest an average target of $22.25, with a high of $30.00 and a low of $14.00. The average price target has increased by 5.95% over the past month. Analysts rate stocks based on future earnings potential and company risk profile, typically updating their ratings quarterly or after significant company events.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 7:00 pm

TFC

Truist Finl (NYSE:TFC) has received 9 analyst ratings in the last quarter with 1 bullish, 3 somewhat bullish, and 5 indifferent. The average price target is $34.89, representing an upside from the current price of $31.72. This is a 3.08% decrease from the previous average price target of $36.00. Analyst ratings are updated quarterly and are used by investors to guide stock decisions.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 7:00 pm